chartexchange

Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates

PR Newswire | Sep 21, 2026 7:00 AM EDT

Controlled manufacturing reproducibly maintains defined genetic diversity across AP-SA02 clinical drug product lots Oral presentation scheduled for today Monday, Sept. 21, 2026 at the 20th International Symposium on Staphylococci and Staphylococcal Infections LOS ANGELES, Sept. 21, 2026...

Read original article